Marcadores de daño miocárdico en la predicción del pronóstico a corto plazo de los pacientes con COVID-19

Calvo-Fernández, Alicia; Izquierdo, Andrea; Subirana, Isaac; Farré, Nuria; Vila, Joan; Durán, Xavier; García-Guimaraes, Marcos; Valdivielso, Sandra; Cabero, Paula; Soler, Cristina; García-Ribas, Cora; Rodríguez, Clara; Llagostera, Marc; Mojón, Diana; Vicente, Miren; Solé-González, Eduard; Sánchez-Carpintero, Andrea; Tevar, Cristina; Marrugat, Jaume; Vaquerizo, Beatriz.
Rev. esp. cardiol. (Ed. impr.) ; 73: 0-0, 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-195988

Documentos relacionados

  1. Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.
  2. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms.
  3. Cardiac Biomarkers and Myocardial Dysfunction in Septicemia.
  4. Cardiac injury is associated with inflammation in geriatric COVID-19 patients.
  5. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
  6. Cancer Survivorship and Subclinical Myocardial Damage.
  7. Elevations in High-Sensitive Cardiac Troponin T and N-Terminal Prohormone Brain Natriuretic Peptide Levels in the Serum Can Predict the Development of Anthracycline-Induced Cardiomyopathy.
  8. Proteomic characterization of serum proteins from Atlantic salmon (Salmo salar L.) from an outbreak with cardiomyopathy syndrome.
  9. Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
  10. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients -  single center experience].